drug · small molecule
moxidectin
Phase 2updated 3mo agoby Atticus Medical Pty Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying moxidectin
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 7, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (1)
- Feb 7, 2028NPPNew Product (3y)1.5y
News(1)
- FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and PuppiesThe U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World scre…fda_press · 7d ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that